• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

A novel targeted gene therapy to incurable sarcomas

Research Project

Project/Area Number 14571414
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Orthopaedic surgery
Research InstitutionOsaka Medical Center for Cancer and Cardiovascular Diseases

Principal Investigator

YAMAMURA Hisako  Research Institute, Department of Molecular Medicine & Pathophysiology, Associate Director, 研究所・病態生理学部門, 主任研究員 (50342994)

Co-Investigator(Kenkyū-buntansha) TAKAHASHI Katsuhito  Research Institute, Dpt of Molecular Medicine & Pathophysiology, Director, 研究所・病態生理学部門, 部長 (40211338)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2003: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 2002: ¥2,500,000 (Direct Cost: ¥2,500,000)
Keywordsleiomyosarcoma / conditionally replicating virus / herpes simplex type I virus / calponin / ICP4 / ヘルペスウイルス / 肉腫 / 遺伝子治療
Research Abstract

To construct an HSV vector that replicates selectively in calponin-positive cells and proliferative cells, a DNA fragment containing the 4F2 enhancer/-260 calponin promoter/ICP4/IRES-EGFP was inserted into the RR (ICP6) locus (U_L36) of the ICP4-deficient HSV mutant d120 (J.Virol.56,558-570,1985) by homologous recombination, and a d12.CALP.ΔRR viral vector was constructed. The d12.CALP.ΔRR viral vector expresses β-galactosidase under the control of an ICP6 promoter, and can express ICP4 protein and EGFP protein under the control of calponin promoter. The calponin-expressing human leiomyosarcoma cell line (SK-LMS-1) and calponin non-expressing human osteosarecma cell line (OST) were used to evaluate the cell selectivity of the viral replication of d12.CALP.ΔRR viral vector. The d12.CALP.ΔRR viral vector was replicated in calponin-positive SK-LMS-1 cells but the titers of d12.CALP.ΔRR viral vector decreased in calponin-negative OST cells 72 hours after infection to approximately 1/100000 … More compared to those of the SK-LMS-1 cells.
When the d12.CALP.ΔRR viral vector is applied to therapies for human malignant tumors, the most important property is that sensitivity to ganciclovir, an anti-herpes viral agent, is indicated since it has TK genes in an intact state. The replication of d12.CALP.ΔRR viral vector was suppressed in the presence of ganciclovir, for SK-LMS-1 cells and Vero E5 cells introduced with ICP4 cDNA. In SK-LMS-1 cells, the replication was completely suppressed in the presence of 40 ng/ml ganciclovir.
B-3 (In vivo treatment and histological analysis)
The in vivo anti-tumor effect of the d12.CALP.ΔRR viral vector against subdermally transplanted tumor xenografts (MFH-AI-LM) that are isolated from MFH-AI cells was examined. The therapeutic effect by one intravenous injection of d12.CALP.ΔRR viral vector against subdennal transplanted tumors of MFH-AI-LM cell lines is expressed as a chronological change in Figure 7. On day 0, the d12.CALP.ΔRR viral vector of 1×10^7 pfu/mouse was infected into the tail vein. The tumor volume (means±S.E.,n=6) of the group on day 29 after being treated with intravenous injection (d12.CALP. ΔRR viral vector administered) and the non-treated group (PBS administered) were 500±136 mm^3 and 183±33 mm^3, respectively. The treated group showed significant anti tumor effect compared to the non-treated group.
The therapeutic effect of d12.CALP.ΔRR viral vector against human lung metastatic tumor by intravenous injection in vivo was examined. The d12.CALP.ΔRR viral vector of 1×10^7 pfu/mouse was injected into the tail vein of a lung metastatic tumor model mouse wherein MFH-AI-LM cells with high metastatic activity to lung isolated from human malignant fibrous histiocytoma MFH-AI cells are used, and metastases tumor in the lung at day 13 and the normal tissues, that is, the brain, heart, liver excised at the same day were subjected to X-Gal staining. By conducting one intravenous administration of d12.CALP.ΔRR viral vector, X-Gal staining which indicates replication of d12.CALP.ΔRR viral vector in the lung metastatic focus and histological tumor necrosis was observed. However, X-Gal staining that indicate the infection and replication of the d12.CALP.ΔRR viral vector in normal tissues such as the brain, heart and liver was not observed. Subsequently, the therapeutic effect of human lung metastatic tumor wherein the number of MFH-AI-LM cells to be administered are set to 1X10^6 or 5X10^5, and the d12.CALP.ΔRR viral vector of 1×10^7 pfu/mouse was intravenously injected for a total of three tines on day 17,day 27 and day 34 after administration of MFH-AI-LM cells was examined For all the lung metastatic tumor models constructed by injecting 1X10^6 or 5X10^5 of MFH-AI-LM tumor cells into the tail vein, the lung metastatic tumor-suppressing effect of the groups administered with d12.CALPΔRR vector was apparent. Less

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (18 results)

All 2003 2002 2001 Other

All Journal Article (10 results) Patent(Industrial Property Rights) (1 results) Publications (7 results)

  • [Journal Article] Role of h1-calponin in pancreatic AR42J cell differentiation into insulin-producing cells.2003

    • Author(s)
      Morioka T., Yamamura H.(他9名, 3番目)
    • Journal Title

      Diabetes 52

      Pages: 760-766

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Journal Article] Role of h1-calponin in pancreatic AR42J cell differentiation into insulin-producing cells.2003

    • Author(s)
      Morioka T., Yamamura H.et al.
    • Journal Title

      Diabetes 52

      Pages: 760-766

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Journal Article] Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone.2002

    • Author(s)
      Ueda, T., Yamamura, H.(他7名, 7番目)
    • Journal Title

      Journal of Clinical Pathology 55

      Pages: 853-858

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Journal Article] Expression of smooth muscle calponin in tumor vessels of human hepatocellular carcinoma and its possible association with prognosis.2002

    • Author(s)
      Sasaki, Y., Yamamura, H., (他9名, 2番目)
    • Journal Title

      Cancer 94

      Pages: 1777-1786

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Journal Article] Smooth muscle calponin in mesangial cells : regulation of expression and a role in suppressing glomerulonephritis.2002

    • Author(s)
      Sugenoya, Y., Yoshimura, A., Yamamura, H.(他6名3番目)
    • Journal Title

      Journal of American Society of Nephrology 13

      Pages: 322-331

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Journal Article] Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone.2002

    • Author(s)
      Ueda, T., Araki, N., Mano, M., Myoui, A., Joyama, S., Ishiguro, S., Yamamura, H, et al.
    • Journal Title

      Journal of Clinical Pathology 55

      Pages: 853-858

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Journal Article] Expression of smooth muscle calponin in tumor vessels of human hepatocellular carcinoma and its possible association with prognosis.2002

    • Author(s)
      Sasaki, Y., Yamamura, H.et al.
    • Journal Title

      Cancer 94

      Pages: 1777-1786

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Journal Article] Smooth muscle calponin in mesangial cells : regulation of expression and a role in suppressing glomerulonephritis.2002

    • Author(s)
      Sugenoya, Y., Yoshimura, A., Yamamura, H., et al.
    • Journal Title

      Journal of American Society of Nephrology 13

      Pages: 322-331

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Journal Article] Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting of a conditionally replicating herpes vector to malignant human soft tissue and bone tumors.2001

    • Author(s)
      Yamamura, H., (他11名, 1番目)
    • Journal Title

      Cancer Research 61

      Pages: 3969-3969

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Journal Article] Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting of a conditionally replicating herpes vector to malignant human soft tissue and bone tumors.2001

    • Author(s)
      Yamamura, H., et al.
    • Journal Title

      Cancer Research 61

      Pages: 3969-3969

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Patent(Industrial Property Rights)] 細胞特異的発現複製ベクター2002

    • Inventor(s)
      高橋克仁, 山村倫子
    • Industrial Property Rights Holder
      JST
    • Industrial Property Number
      2002-255395
    • Filing Date
      2002-08-30
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Morioka, T.et al.: "Role of h1-calponin in pancreatic AR42J cell differentiation into insulin-producing cells."Diabetes. 52. 760-766 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yamamura, H.et al.: "Aberrant methylation and silencing of the calponin gene in human sarcoma cells."Anticancer Research. 23. 107-114 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Kinouchi, T.et al.: "Immature tumor angiogenesis in high-grade and high-stage renal cell carcinoma."Urology. 62. 765-770 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Ueda, T., et al.: "Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone"Journal of Clinical Pathology. 55. 853-858 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Sasaki, Y., et al.: "Expression of smooth muscle calponin in tumor vessels of human hepatocellular carcinoma and its possible association with prognosis"Cancer. 94. 1777-1786 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Sugenoya, Y., et al.: "Smooth muscle calponin in mesangial cells : regulation of expression and a role in suppressing glomerulonephritis"Journal of American Society of Nephrology. 13. 322-331 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Takahashi, K., Yamamura H.: "Studies and perspectives of calponin in smooth muscle regulation and cancer gene therapy"Advances in Biophysics. 37. 91-111 (2003)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi